Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis

Abstract

PHLPP (PH domain leucine-rich repeats protein phosphatase) represents a family of novel Ser/Thr protein phosphatases. Two highly related isoforms in this family, PHLPP1 and PHLPP2, have been identified to serve as negative regulators of Akt and protein kinase C by dephosphorylating the kinases directly. In this study, we examined the expression pattern of both PHLPP isoforms in colorectal cancer specimens and the adjacent normal mucosa using immunohistochemical staining. We found that the expression of PHLPP1 or PHLPP2 isoform was lost or decreased in 78 and 86% of tumor tissues, respectively. Stable overexpression of either PHLPP isoform in colon cancer cells decreased the rate of cell proliferation and sensitized the cells to growth inhibition induced by the phosphoinositide-3 kinase inhibitor, LY294002, whereas knockdown of either PHLPP isoform by shRNA promoted the proliferation of DLD1 cells. In addition, we demonstrated that the PHLPP-mediated growth inhibition in colon cancer cells was largely rescued by overexpression of a constitutively active Akt. Moreover, reexpression of either PHLPP isoform in HCT116 cells inhibited tumor growth in vivo. Taken together, our results strongly support a tumor suppressor role of PHLPP in colon cancer.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Brognard J, Sierecki E, Gao T, Newton AC . (2007). PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 25: 917–931.

    Article  CAS  Google Scholar 

  • Gao T, Brognard J, Newton AC . (2008). The phosphatase PHLPP controls the cellular levels of protein kinase C. J Biol Chem 283: 6300–6311.

    Article  CAS  Google Scholar 

  • Gao T, Furnari F, Newton AC . (2005). PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 18: 13–24.

    Article  CAS  Google Scholar 

  • Gokmen-Polar Y, Murray NR, Velasco MA, Gatalica Z, Fields AP . (2001). Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis. Cancer Res 61: 1375–1381.

    CAS  PubMed  Google Scholar 

  • Hershko DD, Shapira M . (2006). Prognostic role of p27Kip1 deregulation in colorectal cancer. Cancer 107: 668–675.

    Article  CAS  Google Scholar 

  • Kosinski C, Li VSW, Chan ASY, Zhang J, Ho C, Tsui WY et al. (2007). Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc Natl Acad Sci 104: 15418–15423.

    Article  CAS  Google Scholar 

  • Liang J, Slingerland JM . (2003). Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2: 339–345.

    Article  CAS  Google Scholar 

  • Manning BD, Cantley LC . (2007). AKT/PKB signaling: navigating downstream. Cell 129: 1261–1274.

    Article  CAS  Google Scholar 

  • Manning BD, Logsdon MN, Lipovsky AI, Abbott D, Kwiatkowski DJ, Cantley LC . (2005). Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev 19: 1773–1778.

    Article  CAS  Google Scholar 

  • Maroulakou IG, Oemler W, Naber SP, Tsichlis PN . (2007). Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res 67: 167–177.

    Article  CAS  Google Scholar 

  • Murray NR, Davidson LA, Chapkin RS, Clay Gustafson W, Schattenberg DG, Fields AP . (1999). Overexpression of protein kinase C betaII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis. J Cell Biol 145: 699–711.

    Article  CAS  Google Scholar 

  • Nakayama K, Nagahama H, Minamishima YA, Miyake S, Ishida N, Hatakeyama S et al. (2004). Skp2-mediated degradation of p27 regulates progression into mitosis. Dev Cell 6: 661–672.

    Article  CAS  Google Scholar 

  • Newton AC . (2003). Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J 370: 361–371.

    Article  CAS  Google Scholar 

  • Qiao M, Iglehart JD, Pardee AB . (2007). Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activation. Cancer Res 67: 5293–5299.

    Article  CAS  Google Scholar 

  • Reiner A, Neumeister B, Spona J, Reiner G, Schemper M, Jakesz R . (1990). Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res 50: 7057–7061.

    CAS  PubMed  Google Scholar 

  • Rosner M, Freilinger A, Hengstschlager M . (2006). The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27. Mutat Res 613: 10–16.

    Article  CAS  Google Scholar 

  • Saaf AM, Halbleib JM, Chen X, Yuen ST, Leung SY, Nelson WJ et al. (2007). Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer. Mol Biol Cell 18: 4245–4260.

    Article  CAS  Google Scholar 

  • Samuels Y, Diaz Jr LA, Schmidt-Kittler O, Cummins JM, Delong L, Cheong I et al. (2005). Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7: 561–573.

    Article  CAS  Google Scholar 

  • Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S et al. (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554.

    Article  CAS  Google Scholar 

  • Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS et al. (2003). Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9: 493–501.

    Article  CAS  Google Scholar 

  • Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A . (2005). Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 20: 539–550.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank UTMB flow cytometry core for assistance with the flow cytometry analysis, and Dr Alexandra Newton at University of California San Diego for providing the wild-type and mutant Akt and PKC βII expression constructs. This work was supported by NIH K01 CA10209-05 (TG), American Cancer Society RSG0822001TBE (TG) and R01CA104748 (BME).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T Gao.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, J., Weiss, H., Rychahou, P. et al. Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis. Oncogene 28, 994–1004 (2009). https://doi.org/10.1038/onc.2008.450

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2008.450

Keywords

This article is cited by

Search

Quick links